We are live on ! Find out more
CPRC

Consolidated Portfolio Review Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 13.59%
This Fund
S&P 500
This Quarter Est. Return
+6.58%
1 Year Est. Return
+13.59%
3 Year Est. Return
+65.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$448M
AUM Growth
+$19.4M
Cap. Flow
-$4.54M
Cap. Flow %
-1.01%
Top 10 Hldgs %
27.06%
Holding
328
New
33
Increased
155
Reduced
98
Closed
19

Top Buys

Rank Stock Value
1
PI icon
Impinj
PI
+$1.46M
2
AVAV icon
AeroVironment
AVAV
+$1.46M
3
AMZN icon
Amazon
AMZN
+$1.39M
4
ASTL icon
Algoma Steel
ASTL
+$1.24M
5
DHI icon
D.R. Horton
DHI
+$1.15M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.07M
2
NU icon
Nu Holdings
NU
+$2.67M
3
MSFT icon
Microsoft
MSFT
+$2.59M
4
EME icon
Emcor
EME
+$2.42M
5
NVDA icon
NVIDIA
NVDA
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 8.18%
2 Financials 2.45%
3 Real Estate 2.3%
4 Consumer Discretionary 2.1%
5 Communication Services 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMO
51
Western Asset Mortgage Opportunity Fund
DMO
$120M
$2.15M 0.48%
179,515
-8,913
-5% -$108K
UTF icon
52
Cohen & Steers Infrastructure Fund
UTF
$3B
$2.15M 0.48%
82,504
+492
+0.6% +$12.1K
VNQ icon
53
Vanguard Real Estate ETF
VNQ
$38.6B
$2.08M 0.46%
21,335
+1,197
+6% +$110K
RNP icon
54
Cohen & Steers REIT and Preferred and Income Fund
RNP
$976M
$2.07M 0.46%
87,548
+1,739
+2% +$38.9K
PG icon
55
Procter & Gamble
PG
$335B
$2.05M 0.46%
11,811
-606
-5% -$103K
IFN
56
Aberdeen India Fund
IFN
$509M
$2M 0.45%
105,362
+10,121
+11% +$185K
JRI icon
57
Nuveen Real Asset Income & Growth Fund
JRI
$349M
$1.89M 0.42%
138,069
+3,131
+2% +$40.1K
PCN
58
PIMCO Corporate & Income Strategy Fund
PCN
$891M
$1.88M 0.42%
132,232
+2,545
+2% +$34.5K
PI icon
59
Impinj
PI
$5.49B
$1.86M 0.42%
+8,595
New +$1.46M
ACWV icon
60
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.37B
$1.82M 0.41%
15,848
-185
-1% -$20.4K
IJR icon
61
iShares Core S&P Small-Cap ETF
IJR
$112B
$1.8M 0.4%
15,416
+1,570
+11% +$177K
VIG icon
62
Vanguard Dividend Appreciation ETF
VIG
$115B
$1.79M 0.4%
9,057
+136
+2% +$25.9K
BME icon
63
BlackRock Health Sciences Trust
BME
$577M
$1.79M 0.4%
42,574
+2,853
+7% +$118K
BRK.B icon
64
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.78M 0.4%
3,874
-5
-0.1% -$2.21K
LRCX icon
65
Lam Research
LRCX
$408B
$1.77M 0.39%
21,650
+50
+0.2% +$4.35K
XFLT
66
XAI Floating Rate & Alternative Income Trust
XFLT
$292M
$1.73M 0.39%
50,599
+26,496
+110% +$920K
RSP icon
67
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$1.7M 0.38%
9,474
-146
-2% -$24.9K
TSLA icon
68
Tesla
TSLA
$1.29T
$1.62M 0.36%
6,202
-390
-6% -$88.9K
AVAV icon
69
AeroVironment
AVAV
$9.81B
$1.62M 0.36%
+8,081
New +$1.46M
VBK icon
70
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.8B
$1.59M 0.36%
5,952
+104
+2% +$26.6K
INTC icon
71
Intel
INTC
$509B
$1.58M 0.35%
67,331
+187
+0.3% +$4.67K
DSL
72
DoubleLine Income Solutions Fund
DSL
$1.23B
$1.54M 0.34%
118,751
+48,330
+69% +$618K
DGRO icon
73
iShares Core Dividend Growth ETF
DGRO
$43.8B
$1.52M 0.34%
24,321
-77
-0.3% -$4.64K
XLV icon
74
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$1.43M 0.32%
9,281
-311
-3% -$47.1K
GOOGL icon
75
Alphabet (Google) Class A
GOOGL
$4.2T
$1.4M 0.31%
8,465
-14,347
-63% -$2.41M
1 2
3
4 5

Similar funds

AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
SCM
Sone Capital Management New York $1.19B AUM 14% 1-Year Est. Return
MMFA
Main Management Fund Advisors San Francisco, California $1.19B AUM 26.23% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CCS
Concentric Capital Strategies Stamford, Connecticut $1.19B AUM 44.7% 1-Year Est. Return

Consolidated Portfolio Review Corp's Q3 2024 Portfolio in Review

As of Q3 2024, Consolidated Portfolio Review Corp held 328 positions worth $448M, up 4.5% from $429M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Consolidated Portfolio Review Corp's Q3 2024 filing shows 33 new, 155 increased, 98 reduced and 19 closed positions. Its largest new stake was Impinj: 8,595 shares worth $1.86M. The largest sale was Eli Lilly, an estimated $4.07M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 10% a quarter earlier, followed by Financials and Real Estate.

  • Consolidated Portfolio Review Corp's largest Q3 2024 buy was Impinj: 8,595 shares worth $1.86M.
  • Consolidated Portfolio Review Corp added most to Amazon in Q3 2024, an estimated $1.39M increase.
  • Consolidated Portfolio Review Corp's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $4.07M.
  • Consolidated Portfolio Review Corp fully exited Nu Holdings in Q3 2024, selling an estimated $2.67M.
  • Consolidated Portfolio Review Corp's ten largest holdings make up 27% of its $448M portfolio in Q3 2024.
  • Consolidated Portfolio Review Corp opened 33 new positions and closed 19 in Q3 2024.
  • Consolidated Portfolio Review Corp's portfolio value rose 4.5% quarter-over-quarter to $448M.

Based on Consolidated Portfolio Review Corp's 13F filing for Q3 2024, filed 24 Oct 2024.